NCT00572923
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- MAASTRO clinic, Maastricht Radiation Oncology Maastricht, Netherlands
Clinical trial condition
Respiratory Tract Neoplasms
Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.
8,077 public trials
1,842 recruiting studies
Respiratory Tract Neoplasms trial results
NCT00034164
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 3 Cities, Russia
Completed
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
NCT00385177
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +22 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT00167401
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- University of Rochester, Dept. Radiation Oncology Rochester, New York, United States
NCT00087698
- Conditions
- Neoplasms, Neoplasms by Site, Pleural Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
NCT00036023
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +33 more
- Locations
-
Not specified
NCT00096707
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +24 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Institute for Drug Development Cancer Therapy & Research Center San Antonio, Texas, United States
NCT00256711
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site St Leonards, New South Wales, Australia
- Research Site Westmead, New South Wales, Australia
- Research Site South Brisbane, Queensland, Australia
- Research Site Nedlands, Western Australia, Australia
NCT00106626
- Conditions
- Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
Not specified
Completed
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
NCT00087802
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
- Birmingham Hematology and Oncology Associates Birmingham, Alabama, United States
- Hematology Oncology Associates Phoenix, Arizona, United States
- Northern Arizona Hematology & Oncology Associates Sedona, Arizona, United States